The macroscopic biotech that accomplishes what you’re positing is addressed in the first part, and the earlier comment where I note that you’re assuming ASI level understanding of bio for exploring an exponential design space for something that isn’t guaranteed to be possible. The difficulty isn’t unclear, it’s understood not to bebfeasible.
The macroscopic biotech that accomplishes what you’re positing is addressed in the first part, and the earlier comment where I note that you’re assuming ASI level understanding of bio for exploring an exponential design space for something that isn’t guaranteed to be possible. The difficulty isn’t unclear, it’s understood not to bebfeasible.